Literature DB >> 28969652

Transient yellow discoloration of the nails for differential diagnosis with yellow nail syndrome.

Anca Chiriac1,2,3, Adrian Naznean4, Cristian Podoleanu5, Simona Stolnicu6.   

Abstract

A differential diagnosis must be made between transient yellow discoloration of the nails and yellow nail syndrome. We highlight some practical aspects of yellow nail discoloration.

Entities:  

Keywords:  Nail; Yellow discoloration; Yellow nail syndrome

Mesh:

Year:  2017        PMID: 28969652      PMCID: PMC5625644          DOI: 10.1186/s13023-017-0711-4

Source DB:  PubMed          Journal:  Orphanet J Rare Dis        ISSN: 1750-1172            Impact factor:   4.123


Sir, We read with great interest the article by Vignes et al. recently published by the journal [1]. We would like to add some practical issues related to differential diagnosis of yellow nail discoloration. A differential diagnosis must be made between transient yellow discoloration of the nails and yellow nail syndrome. Yellow discoloration of the nails has been reported as an adverse reaction after some drugs such as: quinaqrine used for cutaneous lupus erythematosus [2], after topical use of 5-fluorouracil for the treatment of nail psoriasis (Fig. 1) [3], temsirolimus [4], or bucillamine for rheumatoid arthritis [5], retinoids [6] (Fig. 2). Furthermore, yellow discoloration of the nails has been described during hemodialysis [7], in patients diagnosed with non-Hodgkin lymphoma [8]. Yellow nails can be also observed in patients diagnosed with diabetes mellitus (Fig. 3a, b) [9], tobacco-associated use (Fig. 4), or after intense use of nail polish remover (Fig. 5). In recent years, skin adverse reactions induced by cetuximab have been lately reported; cetuximab is a monoclonal antibody against epidermal growth factor receptor (EGFR) used in the treatment of colorectal cancer [10]. Recently, yellowish distal discoloration was observed in our department in a 67-year-old female patient treated with cetuximab for colorectal cancer (Fig. 6).
Fig. 1

Diffuse yellow discoloration of the nail plate in a case of nail psoriasis treated with topical 5-fluorouracil (close view)

Fig. 2

Yellowish discoloration of finger nails in a teenager while treated with systemic isotretinoin for acne

Fig. 3

“Diabetic yellow nails” (a) and yellow-green discoloration of a nail in a diabetic patient due to Pseudomonas aeruginosa infection (b)

Fig. 4

Tobacco associated yellow nails

Fig. 5

Transient yellow discoloration as a result of nail polish remover (acetone)

Fig. 6

Distal yellowish discoloration of the nail during treatment with cetuximab

Diffuse yellow discoloration of the nail plate in a case of nail psoriasis treated with topical 5-fluorouracil (close view) Yellowish discoloration of finger nails in a teenager while treated with systemic isotretinoin for acne Diabetic yellow nails” (a) and yellow-green discoloration of a nail in a diabetic patient due to Pseudomonas aeruginosa infection (b) Tobacco associated yellow nails Transient yellow discoloration as a result of nail polish remover (acetone) Distal yellowish discoloration of the nail during treatment with cetuximab
  8 in total

1.  Yellow nails in non-Hodgkin lymphoma.

Authors:  Muhammad Saif; Simon Jowitt
Journal:  Br J Haematol       Date:  2006-10-25       Impact factor: 6.998

2.  Yellow nails under bucillamine therapy for rheumatoid arthritis: a report of two cases.

Authors:  T Yamamoto; H Yokozeki
Journal:  Rheumatol Int       Date:  2006-11-14       Impact factor: 2.631

3.  Yellow skin discoloration induced by quinacrine in a patient with cutaneous lupus erythematosus.

Authors:  D Vidal; J Altés; J A Smandia
Journal:  Actas Dermosifiliogr       Date:  2012-07-23

4.  Yellowish discoloration of dialyzer.

Authors:  Yeong-Woei Chiew; Sheng-Jeng Peng; Chwei-Shiun Yang
Journal:  Hemodial Int       Date:  2011-11-22       Impact factor: 1.812

Review 5.  Onychopathy induced by temsirolimus, a mammalian target of rapamycin inhibitor.

Authors:  L Peuvrel; G Quéreux; A Brocard; M Saint-Jean; B Dréno
Journal:  Dermatology       Date:  2012-05-16       Impact factor: 5.366

6.  Yellow nails as an adverse reaction to the topical use of 5-fluorouracil for the treatment of nail psoriasis.

Authors:  Paolo Fiallo
Journal:  J Dermatolog Treat       Date:  2009       Impact factor: 3.359

Review 7.  Management of Skin Reactions During Cetuximab Treatment in Association With Chemotherapy or Radiotherapy: Update of the Italian Expert Recommendations.

Authors:  Carmine Pinto; Carlo A Barone; Giampiero Girolomoni; Elvio G Russi; Marco C Merlano; Daris Ferrari; Evaristo Maiello
Journal:  Am J Clin Oncol       Date:  2016-08       Impact factor: 2.339

Review 8.  Yellow nail syndrome: a review.

Authors:  Stéphane Vignes; Robert Baran
Journal:  Orphanet J Rare Dis       Date:  2017-02-27       Impact factor: 4.123

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.